$LSI Lsi Logic Corp (LSI) Overall Average: 96% Buy. Monday,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$LSI Overall Average: 96% Buy. $NUAN $MAT $TXN

Lsi Logic Corp (LSI) Buy - Hold - Sell - Overall Opinion

LSI Last Price: 11.03
Current Change: +0.04 (+0.36%)

Composite Indicators - Signal
TrendSpotter- Buy

Short Term Indicators
7 Day Average Directional Indicator- Buy
10 - 8 Day Moving Average Hilo Channel- Buy
20 Day Moving Average vs Price- Buy
20 - 50 Day MACD Oscillator- Buy
20 Day Bollinger Bands - Hold

Short Term Indicators Average: 80% Buy
20-Day Average Volume - 23,963,996




Medium Term Indicators
40 Day Commodity Channel Index- Buy
50 Day Moving Average vs Price- Buy
20 - 100 Day MACD Oscillator- Buy
50 Day Parabolic Time/Price- Buy

Medium Term Indicators Average: 100% Buy
50-Day Average Volume - 12,656,414

Long Term Indicators
60 Day Commodity Channel Index- Buy
100 Day Moving Average vs Price- Buy
50 - 100 Day MACD Oscillator- Buy

Long Term Indicators Average: 100% Buy
100-Day Average Volume - 8,566,273

Overall Average: 96% Buy

Price - Support - Pivot Point - Resistance
11.03 10.96 11.02 11.08


Last Updated: Monday, January 6, 2014 08:20:39 AM

LSI Stock Message Board and Forum http://investorshangout.com/search?q=LSI&...mp;yt0=Go!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 5

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 3

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 6

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 9

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 3

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading

Top 5 Most Recently Viewed Articles

Huggies and Walgreens Uniting to Tackle Diaper Need

Updated Category News Views 300

Partnering to Tackle Diaper Needs Huggies and Walgreens are thrilled to kick off a meaningful initiative designed to support families dealing with diaper need. For each pack of Huggies Diapers bought at Walgreens, either in stores or online, Huggies will donate a day's worth of diapers to the National Diaper Bank Network, aiming to contribute as many as one million...

Continue Reading
Surging Growth of Fatty Methyl Ester Sulfonate Market By 2033

Updated Category News Views 144

Exploring the Future of the Fatty Methyl Ester Sulfonate Market The dynamic world of the fatty methyl ester sulfonate (FMES) market is entering an exciting phase of growth. Beginning at an estimated value of US$ 805.9 million in 2024, the forecast projects the market to surge to US$ 2,095.1 million by 2033. This impressive leap represents an annual growth rate of 11.20%,...

Continue Reading
Biden Administration Approves Perpetua's Mining Project

Updated Category News Views 151

Biden Administration Approves Perpetua's Mining Project In a significant move for resource management and economic development, the Biden administration has granted the final mining permit for Perpetua Resources' antimony and gold mine located in Idaho. This decision comes in response to concerns regarding China's substantial control over the global market for antimony, a...

Continue Reading
Neurocrine Biosciences Set to Share Q2 2025 Financial Insights

Updated Category News Views 130

Neurocrine Biosciences Announces Upcoming Financial Conference Call Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a leader in the field of neuroscience, is excited to inform stakeholders about its scheduled conference call and webcast. The event is set for the afternoon of July 30, where financial results for the second quarter of 2025 will be shared. This moment allows...

Continue Reading
Societe Generale Updates on Universal Registration Document

Updated Category News Views 127

Introducing the Second Amendment Societe Generale has exciting news regarding the second amendment to its 2025 Universal Registration Document. This essential document plays a crucial role in ensuring transparency and compliance with regulatory frameworks. The amendment was officially filed with the French Financial Markets Authority (AMF), ensuring that all stakeholders...

Continue Reading